4//SEC Filing
Francois Cedric 4
Accession 0001127602-25-019265
CIK 0001492422other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:11 PM ET
Size
18.7 KB
Accession
0001127602-25-019265
Insider Transaction Report
Form 4
Francois Cedric
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-07-14$20.19/sh−137,465$2,774,923→ 343,433 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-14−65,203→ 110,335 totalExercise: $4.31Exp: 2027-08-20→ Common Stock (65,203 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-15−800→ 109,535 totalExercise: $4.31Exp: 2027-08-20→ Common Stock (800 underlying) - Exercise/Conversion
Common Stock
2025-07-14$4.31/sh+65,203$281,025→ 480,898 total - Exercise/Conversion
Common Stock
2025-07-15$4.31/sh+800$3,448→ 344,233 total - Sale
Common Stock
2025-07-15$20.09/sh−1,900$38,168→ 342,333 total
Holdings
- 472,065(indirect: By Trust)
Common Stock
- 234,411(indirect: By Trust)
Common Stock
- 532,946(indirect: By Trust)
Common Stock
- 300,000(indirect: By Trust)
Common Stock
Footnotes (8)
- [F1]This is a scheduled exercise & sale from 10b5-1 trading plan dated March 10, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $20 - $20.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
- [F3]This transaction was executed in multiple trades at prices ranging from $20 - $20.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
- [F4]The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
- [F5]The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F6]The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
- [F7]The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
- [F8]This option was granted on August 21, 2017 and is fully vested.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001658080
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 4:11 PM ET
- Size
- 18.7 KB